We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Salvarx Group Plc | LSE:SALV | London | Ordinary Share | IM00BZ4SS228 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/2/2021 17:22 | Average value of Clinical Stage US bios on NASDAQ meant to be circa $1-2bn Looks as easy multibagger to me | the stigologist | |
11/2/2021 17:20 | About 10 days ago Ian had told me to be patient! | bscuit | |
11/2/2021 16:13 | This will fly once its on a more liquid market. Hold on tight. | bobby.ifa | |
11/2/2021 16:05 | BRILLIANT news Can't wait to buy this 25th February PORTAGE BIOTECH PROVIDES RESEARCH AND DEVELOPMENT UPDATE AND ANNOUNCES NASDAQ LISTING APPROVAL -- Company to advance three clinical-stage programs in pipeline -- -- Portage has received approval and is preparing for NASDAQ listing -- Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") today announced its 2021 research and development goals, including advancing three of its pipeline assets through clinical trials during the upcoming year. Portage also announced that it has received approval from the NASDAQ Capital Market ("NASDAQ") to list its common shares on the NASDAQ exchange, and expects to commence trading February 25, 2021 under the symbol "PRTG." | the stigologist | |
04/2/2021 21:50 | Just done a search of this bb and with the current price of Portage it will be worth around 30p per salvarx share less expenses ( for absolutely nothing ). It’s been so long since they last said they hoped to have a deal confirmed. Maybe just wind it up. | mellonsbellend | |
04/2/2021 21:41 | Biscuit. The company is a shell . But from memory I believe with the Portage shares they hold it would be equivalent to around 20p a share less any expenses Do you think they will just wind it up ? | mellonsbellend | |
31/1/2021 12:59 | Bscuit, I am with EQi. If they list on Nasdaq I think I will be OK as they deal with the traded exchanges. | minky | |
31/1/2021 10:49 | The company is a shell and there is zero prospect of a Re-listing. I haven’t tried to sell my PTGEF shares- currently up 9x - as I look for a Nasdaq listing, but which broker are you with? | bscuit | |
31/1/2021 06:17 | I have a few Portage shares but I seem to be unable to sell them in the UK. They are on a matched bargain basis I believe. Does any one know how I can trade them through a broker? Looking at the above posts I will wait a while but need to know for the future unless they get relisted. | minky | |
31/1/2021 00:13 | There were 60.8M Portage shares now consolidated at 608,000 valued @$US23 plus any cash value from warrants held by SALV, though I don’t know number of shares in issue. Curiously I cannot find SALV on CH Webcheck to check shares in issue. Company maintenance costs will have had to be paid - presumably from share sales. The Listing has now no value in my opinion as it was an AiM company. | bscuit | |
30/1/2021 22:15 | Completely lost track. Will try to look it up | the stigologist | |
30/1/2021 19:44 | Stig. How many shares did salvarx have as a company and how many shares in Portage did they hold? Do you know what will happen with this company? | mellonsbellend | |
20/1/2021 21:27 | PTGEF Intensity Therapeutic Presentation 'Eradicating Cancer' | the stigologist | |
20/1/2021 15:27 | $25 Conference going off today Presentation seems to be going well | the stigologist | |
19/1/2021 22:19 | Breakout to new 1 and 3 year highs Intensity Therapeutics presenting at a Conference today | the stigologist | |
19/1/2021 15:39 | Sheesh PTGEF $25 intraday today ? Currently $22 | the stigologist | |
11/1/2021 21:26 | Consolidating nicely in a bull flag at $18 | the stigologist | |
31/12/2020 18:38 | Great finish to the year $18.35 | the stigologist | |
31/12/2020 17:51 | Nice exposure to what looks like compelling upside potential on a one year view I suspect the SALV guys will either simply look to liquidate the Company and return funds or holdings in-specie | the stigologist | |
31/12/2020 17:13 | Unless SALV have disposed of their Portage shares, I believe they still own 566,575 shares which would equate to $9.77 million @ 17.25 mid price currently. This would equate to 19.5p per old SALV share. I still own 334,762 of the old SALV shares so am hoping for dome news from them in the not too distant future! Just hoping they haven't sold many of their Portage shares in order to ''cover expenses'' and shafted the shareholders - heres hoping! Still hold 10,000 PTGEF shares from SALV days, so currently very happy, hoping foe news to make me ''ecstatic''!!!! | cumbrian2 | |
31/12/2020 17:11 | This is an interesting old read though | the stigologist | |
31/12/2020 17:03 | No idea. Not heard anything. Website is dead www.salvarx.io | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions